Calanthe mishmensis
Calanthe mishmensis · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Calanthe mishmensis is an intriguing botanical species that has recently garnered scientific interest due to its unique chemical profile. Research focusing on the plant's MeOH extract has revealed a complex array of secondary metabolites. Among these constituents, the compound methylisatoid has been identified as a significant component of its chemical makeup. Preliminary studies indicate that these substances exhibit notable cytotoxic activities against various cell lines. Consequently, this orchid holds substantial potential for further investigation within the field of pharmacological development.
- Synonyms
- Calanthe Crinita · Phaius Roseus · 7 more
- Common names
- Not available
- Family
- Orchidaceae
- Distribution
- Northern America
- Plant Parts
- Not available
Classification
Common Names
Calanthe mishmensis is a distinctive orchid species known by several descriptive names in different regions. In certain contexts, it is referred to by the common name ヒメカクラン. It is also frequently identified by the Japanese name 細莖鶴頂蘭, which highlights its specific botanical characteristics. These varying names help enthusiasts and researchers categorize the plant within its unique cultural and scientific landscape. Understanding these various monikers is essential for anyone studying the diverse nomenclature of this beautiful orchid.
Sources: Catalogue of Life (COL)
Synonyms
Calanthe mishmensis is a botanical subject that has been classified under several different names throughout its taxonomic history. Scientific literature identifies various synonyms for this species, including the designations Calanthe crinita and Calanthe ramosa. It has also been previously referred to by the name Limatodis mishmensis in certain studies. Furthermore, its classification history links it to the names Phaius augustinianus and Phaius crinita. Understanding these various nomenclatural relationships is essential for accurate identification in orchidology.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Calanthe mishmensis is a remarkable species that belongs to the vast kingdom Plantae. As a member of the diverse order Asparagales, it showcases the intricate biological complexity found within its lineage. This plant is specifically classified under the class Equisetopsida, reflecting its evolutionary place in the botanical world. Within its taxonomic hierarchy, it is nested in the family Orchidaceae, highlighting its connection to other exotic blooms. Ultimately, its identity is defined by its placement within the distinguished genus Calanthe.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Asparagales |
| Family | Orchidaceae |
| Genus | Calanthe |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Calanthe mishmensis is a distinctive plant species with a wide geographic presence across various temperate regions of Asia. Its natural distribution encompasses much of China, including the South-Central and Southeast provinces as well as the high altitudes of Tibet. Beyond the mainland, the species can also be found throughout the Eastern Asian landscape. Specifically, its range extends to the islands of Nansei-shoto and the lush terrain of Taiwan. This broad coverage highlights the plant's ability to thrive within diverse ecological niches across the continent.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Biological Activities
Calanthe mishmensis, also referred to in recent studies as Phaius mishmensis, has demonstrated significant cytotoxic activity through its chemical constituents. Researchers utilized bioassay-guided chromatographic separation to isolate several unique compounds, including six new indoloquinazolinones known as phaitanthrins A-E. Among these, phaitanthrin A and tryptanthrin were found to exhibit moderate cytotoxicity against specific human cancer cell lines, such as MCF-7, NCI-H460, and SF-268. To further explore this potential, a series of ketone adducts were synthesized and tested for their anticancer properties in vitro. The results indicated that specific derivatives, such as the 3-pentanone adduct, maintain an activity level similar to that of tryptanthrin.
Compounds
Calanthe mishmensis has been identified as a significant source of unique chemical compounds during recent phytochemical investigations. Through the bioassay-guided chromatographic separation of its methanol extract, researchers successfully isolated several noteworthy substances. Among these findings, the plant was found to contain methylisatoid, which was identified alongside a series of new indoloquinazolinones. The structural elucidation of these components was achieved through rigorous spectroscopic analysis to ensure accuracy. These discoveries contribute to a broader understanding of the bioactive potential inherent in the species.
Conditions
Calanthe mishmensis exhibits significant therapeutic potential through its ability to treat various cancer cell lines. Specifically, compounds derived from this plant demonstrate moderate cytotoxicity against MCF-7 cells. The plant's extracts also show effectiveness in treating NCI-H460 cell lines. Furthermore, the bioactive components found within the species are capable of treating SF-268 cells. These findings highlight the specific anticancer activities associated with the chemical constituents of the plant.
Preparations
Calanthe mishmensis is prepared as a MeOH extract to facilitate the isolation of bioactive compounds. This methanol extraction process serves as the foundation for bioassay-guided chromatographic separation. Through this method, researchers successfully identified several indoloquinazolinones, including the phaitanthrins. The cytotoxic properties of the plant are specifically linked to these compounds derived from the extract. Consequently, the MeOH extract provides the necessary chemical precursors for studying anticancer activities against various human cancer cell lines.